Evidence mapPaperPMID 28553146Full record

ReviewInternational journal of women's health2017

Recurrent pregnancy loss: current perspectives.

Hady El Hachem, Vincent Crepaux, Pascale May-Panloup, Philippe Descamps, Guillaume Legendre, Pierre-Emmanuel Bouet

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of women's health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 178 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 5 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04558268 phase2 / phase3unknown statusnot on this mapstarted 2020, after this paper: background citation

Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss

TypeinterventionalSponsorSoroka University Medical CenterRan2020 to 2021Enrolled242ConditionsRecurrent Pregnancy Loss(RPL), Recurrent MiscarriageArmsPrednisone, Progesterone, vit D, Iron Supplement, Folic Acid
NCT05341856 early_phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With Unexplained Recurrent Pregnancy Loss

TypeinterventionalSponsorAl-Azhar UniversityRan2022 to 2022Enrolled60ConditionsRecurrent Pregnancy LossArmsisosorbide mononitrate, Placebo
3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 5 syntheses or guidelines pooled it, 442 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Immune activation induced by FOLR2Frontiers in immunology · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Association Study of Hyaluronan-Binding Protein 2 (International journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Dysfunctional Decidual CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hady El HachemDepartment of Reproductive Medicine, Ovo Clinic, Montréal, QC, Canada.
Vincent CrepauxDepartment of Obstetrics and Gynecology, Angers University Hopsital, Angers, France.
Pascale May-PanloupDepartment of Reproductive Biology, Angers University Hospital, Angers, France.
Philippe DescampsDepartment of Obstetrics and Gynecology, Angers University Hopsital, Angers, France.
Guillaume LegendreDepartment of Obstetrics and Gynecology, Angers University Hopsital, Angers, France.
Pierre-Emmanuel BouetDepartment of Obstetrics and Gynecology, Angers University Hopsital, Angers, France.
Université d'Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent pregnancy loss is an important reproductive health issue, affecting 2%-5% of couples. Common established causes include uterine anomalies, antiphospholipid syndrome, hormonal and metabolic disorders, and cytogenetic abnormalities. Other etiologies have been proposed but are still considered controversial, such as chronic endometritis, inherited thrombophilias, luteal phase deficiency, and high sperm DNA fragmentation levels. Over the years, evidence-based treatments such as surgical correction of uterine anomalies or aspirin and heparin for antiphospholipid syndrome have improved the outcomes for couples with recurrent pregnancy loss. However, almost half of the cases remain unexplained and are empirically treated using progesterone supplementation, anticoagulation, and/or immunomodulatory treatments. Regardless of the cause, the long-term prognosis of couples with recurrent pregnancy loss is good, and most eventually achieve a healthy live birth. However, multiple pregnancy losses can have a significant psychological toll on affected couples, and many efforts are being made to improve treatments and decrease the time needed to achieve a successful pregnancy. This article reviews the established and controversial etiologies, and the recommended therapeutic strategies, with a special focus on unexplained recurrent pregnancy losses and the empiric treatments used nowadays. It also discusses the current role of preimplantation genetic testing in the management of recurrent pregnancy loss.

Indexed as

antiphospholipid syndromepreimplantation genetic diagnosispreimplantation genetic screeningrecurrent miscarriagerecurrent pregnancy loss

Identifiers

PMID28553146
PMCPMC5440030
OpenAlexW2614898738

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.